Literature DB >> 8836188

Cloning and characterization of the gene for the somatic form of DNA topoisomerase I from Xenopus laevis.

S D Pandit1, R E Richard, R Sternglanz, D F Bogenhagen.   

Abstract

Two distinct tissue-specific forms of DNA topoisomerase I with M(r) of 165 and 110 kDa have been purified from oocytes and somatic cells respectively of the African frog Xenopus laevis. In this paper, cDNAs encoding a Xenopus topoisomerase I were cloned using PCR primers derived from sequences of yeast and human topoisomerase I. A polypeptide expressed from a portion of the coding sequence was recognized by an antiserum directed against the somatic topoisomerase I that had previously been shown to be unable to cross-react with the oocyte enzyme. Thus, the clone encodes the somatic cell topoisomerase I. An antiserum raised against a synthetic peptide containing the sequence surrounding the active site tyrosine of the somatic topoisomerase I reacts with the enzymes purified from both oocytes and somatic cells, indicating that the two enzymes share some limited sequence homology. RNA blot hybridization showed that oocytes contain an abundant store of somatic topoisomerase I mRNA that is not efficiently polyadenylated in oocytes. This stored RNA contains a consensus cytoplasmic polyadenylation element that is found in a variety of mRNAs that are translationally repressed in oocytes. Microinjection into oocytes of in vitro transcribed mRNA prepared from a Myc-tagged construct of the somatic topoisomerase I sequence is translated to yield a 110 kDa product. This suggests that the oocyte-specific 165 kDa topoisomerase I is not produced by tissue-specific post-translational modification of the somatic topoisomerase I. The oocyte enzyme appears to be produced from a minor mRNA species in oocytes that has not yet been identified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836188      PMCID: PMC146146          DOI: 10.1093/nar/24.18.3593

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

Review 1.  A maternal tail of poly(A): the long and the short of it.

Authors:  R F Bachvarova
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

2.  Structure of the human type I DNA topoisomerase gene.

Authors:  N Kunze; G C Yang; M Dölberg; R Sundarp; R Knippers; A Richter
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

Review 3.  Structure and function of type II DNA topoisomerases.

Authors:  P M Watt; I D Hickson
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

4.  The use of Xenopus oocytes for the expression of cloned genes.

Authors:  J B Gurdon; M P Wickens
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Poly(ADP-ribosylation) of a DNA topoisomerase.

Authors:  A M Ferro; N P Higgins; B M Olivera
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

6.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors:  H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

7.  Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin.

Authors:  E Rubin; P Pantazis; A Bharti; D Toppmeyer; B Giovanella; D Kufe
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

8.  Isolation and characterization of a gene encoding DNA topoisomerase I in Drosophila melanogaster.

Authors:  T S Hsieh; S D Brown; P Huang; J Fostel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

9.  Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.

Authors:  P Benedetti; P Fiorani; L Capuani; J C Wang
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

10.  A role for transcription and FRGY2 in masking maternal mRNA within Xenopus oocytes.

Authors:  P Bouvet; A P Wolffe
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.